RecruitingNot ApplicableNCT06100263
Breast Cancer Resiliency Through Exercise Program (B-REP)
Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study
Sponsor
University of Michigan Rogel Cancer Center
Enrollment
75 participants
Start Date
May 28, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria7
- Women will be eligible if they meet the following criteria:
- self-identify as Black or African American or Afro-Latina/e;
- are ≥18 years old;
- have a confirmed diagnosis of breast cancer, Stage I to IIIA;
- have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable;
- are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and
- are able to speak and understand English.
Exclusion Criteria7
- metastatic disease;
- medical reason that precludes them from increasing current exercise levels;
- planned elective surgery during study period;
- pregnant or plans to become pregnant during the study period;
- plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States);
- current enrollment in another exercise trial; and/or
- inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.
Interventions
OTHERIndividualized exercise program
guided exercise program for 12 weeks
OTHERControl Arm
Control Arm Waiting List for 24 weeks, then offered a guided exercise program for 12 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06100263
Related Trials
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
NCT065076184 locations
GammaPod Registry and Quality of Life Nomogram
NCT035622734 locations
Cognitive Rehabilitation Following Breast Cancer Treatment
NCT065450451 location
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy
NCT065520911 location
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
NCT072421182 locations